Ge Healthcare (GEHC) | Financial Analysis & Statements
Ge Healthcare Technologies Inc. Large-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
5.7B
Gross Profit
2.3B
39.68%
Operating Income
827.0M
14.51%
Net Income
602.0M
10.57%
Balance Sheet Metrics
Total Assets
36.9B
Total Liabilities
26.3B
Shareholders Equity
10.6B
Debt to Equity
2.48
Cash Flow Metrics
Operating Cash Flow
1.3B
Free Cash Flow
916.0M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Ge Healthcare Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 20.6B | 19.7B | 19.6B | 18.3B | 17.6B |
| Cost of Goods Sold | 12.4B | 11.5B | 11.6B | 11.2B | 10.4B |
| Gross Profit | 8.2B | 8.2B | 7.9B | 7.2B | 7.2B |
| Gross Margin % | 40.0% | 41.7% | 40.5% | 39.1% | 40.8% |
| Operating Expenses | |||||
| Research & Development | 1.3B | 1.3B | 1.2B | 1.0B | 816.0M |
| Selling, General & Administrative | 4.2B | 4.3B | 4.3B | 3.6B | 3.6B |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 5.5B | 5.6B | 5.5B | 4.7B | 4.4B |
| Operating Income | 2.8B | 2.6B | 2.4B | 2.5B | 2.8B |
| Operating Margin % | 13.4% | 13.3% | 12.5% | 13.8% | 15.9% |
| Non-Operating Items | |||||
| Interest Income | 41.0M | - | 26.0M | - | 34.0M |
| Interest Expense | 440.0M | 505.0M | 542.0M | 86.0M | 40.0M |
| Other Non-Operating Income | 404.0M | 462.0M | 442.0M | 76.0M | 86.0M |
| Pre-tax Income | 2.8B | 2.6B | 2.4B | 2.5B | 2.9B |
| Income Tax | 614.0M | 531.0M | 743.0M | 563.0M | 600.0M |
| Effective Tax Rate % | 22.2% | 20.6% | 31.5% | 22.4% | 20.9% |
| Net Income | 2.2B | 2.0B | 1.6B | 2.0B | 2.3B |
| Net Margin % | 10.4% | 10.4% | 8.3% | 10.7% | 13.0% |
| Key Metrics | |||||
| EBITDA | 3.7B | 3.7B | 3.5B | 3.2B | 3.5B |
| EPS (Basic) | $4.56 | $4.37 | $3.05 | $4.63 | $4.94 |
| EPS (Diluted) | $4.55 | $4.34 | $3.03 | $4.63 | $4.94 |
| Basic Shares Outstanding | 456000000 | 456000000 | 455000000 | 413822894 | 454710004 |
| Diluted Shares Outstanding | 456000000 | 456000000 | 455000000 | 413822894 | 454710004 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Ge Healthcare Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 4.5B | 2.9B | 2.5B | 1.4B | 554.0M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 3.7B | 3.4B | 3.3B | 3.1B | 3.0B |
| Inventory | 2.2B | 1.9B | 2.0B | 2.2B | 1.9B |
| Other Current Assets | 81.0M | 12.0M | 61.0M | 94.0M | 88.0M |
| Total Current Assets | 12.5B | 9.9B | 9.4B | 8.3B | 7.0B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 410.0M | 364.0M | 356.0M | 313.0M | 358.0M |
| Goodwill | 28.1B | 27.4B | 27.1B | 27.1B | 27.6B |
| Intangible Assets | 1.1B | 1.1B | 1.3B | 1.5B | 1.8B |
| Long-term Investments | 88.0M | - | - | - | - |
| Other Non-Current Assets | 5.5B | 5.4B | 5.3B | 2.2B | 2.0B |
| Total Non-Current Assets | 24.4B | 23.2B | 23.0B | 19.2B | 19.3B |
| Total Assets | 36.9B | 33.1B | 32.5B | 27.5B | 26.3B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 3.2B | 3.0B | 2.9B | 2.9B | 2.5B |
| Short-term Debt | 642.0M | 1.6B | 1.1B | 119.0M | 110.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 651.0M | 711.0M | 951.0M | 804.0M | 860.0M |
| Total Current Liabilities | 9.1B | 9.6B | 9.0B | 7.2B | 6.8B |
| Non-Current Liabilities | |||||
| Long-term Debt | 9.8B | 7.8B | 8.7B | 8.5B | 327.0M |
| Deferred Tax Liabilities | 193.0M | 56.0M | 68.0M | 370.0M | 385.0M |
| Other Non-Current Liabilities | 203.0M | 208.0M | 460.0M | 321.0M | 318.0M |
| Total Non-Current Liabilities | 17.2B | 14.9B | 16.2B | 10.8B | 2.7B |
| Total Liabilities | 26.3B | 24.4B | 25.1B | 17.9B | 9.4B |
| Equity | |||||
| Common Stock | 5.0M | 5.0M | 5.0M | 11.2B | 17.7B |
| Retained Earnings | 5.3B | 3.3B | 1.3B | 0 | - |
| Treasury Stock | 225.0M | 25.0M | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 10.6B | 8.7B | 7.3B | 9.6B | 16.9B |
| Key Metrics | |||||
| Total Debt | 10.5B | 9.4B | 9.9B | 8.6B | 437.0M |
| Working Capital | 3.4B | 348.0M | 429.0M | 1.1B | 239.0M |
Balance Sheet Composition
Ge Healthcare Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 2.2B | 2.0B | 1.6B | 1.9B | 2.3B |
| Depreciation & Amortization | 578.0M | 580.0M | 610.0M | 633.0M | 625.0M |
| Stock-Based Compensation | 130.0M | 125.0M | 114.0M | 67.0M | 76.0M |
| Working Capital Changes | -153.0M | 2.0M | -47.0M | -223.0M | -1.3B |
| Operating Cash Flow | 3.0B | 3.2B | 3.3B | 3.0B | 2.2B |
| Investing Activities | |||||
| Capital Expenditures | -482.0M | -401.0M | -386.0M | -306.0M | -233.0M |
| Acquisitions | -378.0M | -313.0M | -147.0M | 0 | -1.5B |
| Investment Purchases | -118.0M | -40.0M | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -1.0B | -914.0M | -558.0M | -398.0M | -1.8B |
| Financing Activities | |||||
| Share Repurchases | -200.0M | - | - | - | - |
| Dividends Paid | -64.0M | -55.0M | -41.0M | 0 | 0 |
| Debt Issuance | 2.7B | 995.0M | 2.0B | 8.2B | 5.0M |
| Debt Repayment | -1.8B | -1.4B | -855.0M | -3.0M | -10.0M |
| Financing Cash Flow | 580.0M | -606.0M | -478.0M | -822.0M | -263.0M |
| Free Cash Flow | 1.5B | 1.6B | 1.7B | 1.8B | 1.4B |
| Net Change in Cash | 2.6B | 1.7B | 2.3B | 1.8B | 214.0M |
Cash Flow Trend
Ge Healthcare Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
15.92
Forward P/E
13.02
Price to Book
3.18
Price to Sales
1.60
PEG Ratio
-0.87
Profitability Ratios
Profit Margin
10.10%
Operating Margin
15.73%
Return on Equity
22.38%
Return on Assets
5.47%
Financial Health
Current Ratio
1.37
Debt to Equity
98.72
Beta
1.30
Per Share Data
EPS (TTM)
$4.55
Book Value per Share
$22.77
Revenue per Share
$45.23
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| GEHC | 31.9B | 15.92 | 3.18 | 22.38% | 10.10% | 98.72 |
| Veeva Systems | 26.5B | 29.57 | 3.66 | 13.93% | 28.45% | 1.33 |
| Tempus AI | 9.4B | 39.30 | 18.89 | -89.48% | -19.27% | 270.11 |
| MSP Recovery | 22.4M | 3.60 | 0.17 | -59.11% | 72.16% | 70.91 |
| MSP Recovery | 38.1K | - | 0.00 | -59.11% | 72.16% | 70.91 |
| BrightSpring Health | 9.3B | 100.33 | 5.24 | 5.92% | 1.48% | 143.60 |
Financial data is updated regularly. All figures are in the company's reporting currency.




